Found 11 matching trials
Effisayil™ ON: A Study to Test Long-term Treatment With Spesolimab in People With Generalized Pustular Psoriasis Who Took Part in a Previous Study PHASE2 This study is open to people with generalized pustular psoriasis (GPP). Peo...
Show More Status
Active Not Recruiting
Location
Oakland Hills Dermatology
Learn More & Join Trial
A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa PHASE2 This study is open to adults with a chronic inflammatory skin disease calle...
Show More Location
Dermatology Research Associates
Learn More & Join Trial
Effisayil™ 1: A Study to Test Spesolimab (BI 655130) in Patients With a Flare-up of a Skin Disease Called Generalized Pustular Psoriasis PHASE2 To evaluate efficacy, safety, and tolerability of spesolimab (BI 655130) co...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
A Study in Patients With Atopic Eczema to Test How Effective BI 655130 is and How Well it is Tolerated PHASE2 The primary objective of this trial is to investigate the safety, tolerabil...
Show More Location
Center for Dermatology and Plastic Surgery
Learn More & Join Trial
BI 655130 Long-term Treatment in Patients With moderate-to Severe Ulcerative Colitis PHASE2 To evaluate the long-term safety of BI 655130 (SPESOLIMAB) in patients with...
Show More Location
Medical Research Center of Connecticut, LLC
Learn More & Join Trial
An Expanded Access Trial in Japan to Provide Spesolimab to People With a Flare-up in Generalized Pustular Psoriasis Who Have no Other Treatment Options PHASE3 This Expanded Access trial in Japan is open to people with a serious skin d...
Show More Location
Nagoya City University Hospital
Learn More & Join Trial
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum PHASE3 The purpose of this study is to find out whether a medicine called spesolim...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
A Trial in Healthy Chinese Volunteers to Test How Different Doses of BI 655130 Are Taken up in the Body PHASE1 The primary objective of this trial is to investigate pharmacokinetics, inc...
Show More Location
Huashan Hospital, Fudan University
Learn More & Join Trial
BI655130 (SPESOLIMAB) Induction Treatment in Patients With Moderate-to-severe Ulcerative Colitis PHASE2 This trial has two sequentially enrolling parts with different objectives. ...
Show More Location
Medical Research Center of Connecticut, LLC
Learn More & Join Trial
A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Netherton Syndrome PHASE2 This study is open to people with a skin disease called Netherton syndrome ...
Show More Location
Mission Dermatology Center
Learn More & Join Trial